Near-infrared deep brain stimulation via upconversion nanoparticle-mediated optogenetics.
Shuo ChenAdam Z WeitemierXiao ZengLinmeng HeXiyu WangYanqiu TaoArthur J Y HuangYuki HashimotodaniMasanobu KanoHirohide IwasakiLaxmi Kumar ParajuliShigeo OkabeDaniel Boon Loong TehAngelo Homayoun AllIku Tsutsui-KimuraKenji F TanakaXiaogang LiuThomas J McHughPublished in: Science (New York, N.Y.) (2018)
Optogenetics has revolutionized the experimental interrogation of neural circuits and holds promise for the treatment of neurological disorders. It is limited, however, because visible light cannot penetrate deep inside brain tissue. Upconversion nanoparticles (UCNPs) absorb tissue-penetrating near-infrared (NIR) light and emit wavelength-specific visible light. Here, we demonstrate that molecularly tailored UCNPs can serve as optogenetic actuators of transcranial NIR light to stimulate deep brain neurons. Transcranial NIR UCNP-mediated optogenetics evoked dopamine release from genetically tagged neurons in the ventral tegmental area, induced brain oscillations through activation of inhibitory neurons in the medial septum, silenced seizure by inhibition of hippocampal excitatory cells, and triggered memory recall. UCNP technology will enable less-invasive optical neuronal activity manipulation with the potential for remote therapy.
Keyphrases
- visible light
- deep brain stimulation
- photodynamic therapy
- cerebral ischemia
- spinal cord
- resting state
- white matter
- parkinson disease
- fluorescence imaging
- functional connectivity
- obsessive compulsive disorder
- drug release
- induced apoptosis
- fluorescent probe
- working memory
- blood brain barrier
- stem cells
- brain injury
- high resolution
- uric acid
- metabolic syndrome
- endoplasmic reticulum stress
- spinal cord injury
- replacement therapy
- drug induced
- endothelial cells
- cell cycle arrest
- multiple sclerosis
- smoking cessation
- drug delivery
- temporal lobe epilepsy